Growth Metrics

Ocugen (OCGN) Operating Income Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Ocugen 452.01 Mn 452.01 Mn - -23.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23.02%
Dec 31, 2025 -22.80%
Sep 30, 2025 -33.00%
Jun 30, 2025 10.71%
Mar 31, 2025 -18.70%
Dec 31, 2024 -20.09%
Sep 30, 2024 -6.60%
Jun 30, 2024 34.37%
Mar 31, 2024 32.27%
Dec 31, 2023 50.65%
Sep 30, 2023 50.49%
Jun 30, 2023 -9.10%
Mar 31, 2023 5.23%
Dec 31, 2022 -60.27%
Sep 30, 2022 -132.74%
Jun 30, 2022 15.75%
Mar 31, 2022 -169.66%
Dec 31, 2021 -282.67%
Sep 30, 2021 -5.96%
Jun 30, 2021 -660.84%
Mar 31, 2021 -79.61%
Dec 31, 2020 11.02%
Sep 30, 2020 -275.19%
Jun 30, 2020 -44.56%
Mar 31, 2020 18.84%
Dec 31, 2019 24.78%
Sep 30, 2019 -12.87%
Jun 30, 2019 68.03%
Mar 31, 2019 20.55%
Dec 31, 2018 5.69%
Sep 30, 2018 57.91%
Jun 30, 2018 -14.28%
Mar 31, 2018 10.79%
Dec 31, 2017 23.69%
Sep 30, 2017 14.06%
Jun 30, 2017 19.87%
Mar 31, 2017 12.41%
Dec 31, 2016 4.91%
Sep 30, 2016 17.30%
Jun 30, 2016 -4.77%
Mar 31, 2016 0.95%
Dec 31, 2015 -27.14%
Sep 30, 2015 46.19%
Jun 30, 2015 -26.34%
Mar 31, 2015 -52.19%